8-KEarnings & ResultsExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Financial Results (Oct 20, 2005)

Filed October 20, 2005For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) filed an 8-K on October 20, 2005, primarily to report its financial results for the third quarter and the first nine months of 2005. This filing serves as an official notification to investors of the company's performance during the period ending September 30, 2005, as detailed in an accompanying press release. While the 8-K itself does not contain the specific financial figures, it directs investors to Exhibit 99.1, the press release, for the detailed earnings announcement. This is a standard procedure for companies to disseminate timely financial information. Investors should refer to the attached press release for key metrics such as revenue, earnings per share, and any forward-looking statements or guidance provided by the company.

Key Highlights

  • 1Quest Diagnostics Incorporated filed an 8-K report on October 20, 2005.
  • 2The filing's primary purpose is to announce financial results for the quarter and nine months ended September 30, 2005.
  • 3The detailed financial results are provided in an attached press release, Exhibit 99.1.
  • 4The report falls under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits).
  • 5The Chief Financial Officer, Robert A. Hagemann, signed the report, indicating official company acknowledgment of the disclosed information.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially announce Quest Diagnostics Incorporated's financial results for the third quarter and the first nine months of the fiscal year ending September 30, 2005.

The specific financial details, including revenue, earnings, and other performance metrics, are contained within the press release attached as Exhibit 99.1 to this 8-K filing.

The report was signed by Robert A. Hagemann, Senior Vice President and Chief Financial Officer of Quest Diagnostics Incorporated, indicating his authorization of the disclosed financial information.